|
02-15
|
ATR kinase: a novel cellular target for anti- retroviral drug discovery and therapy
Patent No. US7736848B2; Summary
|
Anna Marie Skalka
|
Natalia Shalginskikh
|
|
03-13
|
Targeted therapy for ovarian cancer: Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to Detect and Treat Cancer
Patent No. US7781568B2;
Patent No. US8198411B2; Summary
|
Gregory Adams
|
Tatiana Venkova
|
|
06-16
|
Treatment of diseases associated with aberrant ciliary function
Patent No. US8685658B2; Summary
|
Erica Golemis
|
Natalia Shalginskikh
|
|
07-05
|
Compositions and Methods for Altering Pancreas and Liver Functions
Patent No. US8329467B2
|
Kenneth Zaret
|
Tatiana Venkova
|
|
07-29
|
Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and antiviral agents
Patent No. US8557241B2; Summary
|
Luis Sigal
|
Natalia Shalginskikh
|
|
07-40
|
EFGR/NEDD9/TGF-β Interactome and Methods for the Identification of Agents for the Treatment of Hyperproliferative Disorders
Patent No.US10450613B2; Summary
|
Igor Astsaturov
|
Natalia Shalginskikh
|
|
104-JT
|
Methods to Treat Hepatitis B and other Liver Disorders
Patent No. US8748373B2; Summary
|
John Taylor
|
Natalia Shalginskikh
|
|
108-YM
|
Synergistic Cytotoxic Effects of 5-Fluorouracil Derivatives and 5-Hydroxymethyluracil Derivatives
Patent No. US8617540B2
|
Yoshihiro Matsumoto
|
Natalia Shalginskikh
|
|
114-EH
|
Method for the Treatment of Lymphangioleiomyomatosis (LAM)
Patent No. US8530457B2
|
Elizabeth Henske
|
Natalia Shalginskikh
|
|
115-IR
|
Use of Synthetic Peptides for the Prevention and Treatment of Breast Cancer
Patent No. US8969304B2
|
Irma Russo
|
Natalia Shalginskikh
|
|
151-EG
|
Combination Therapy for the Treatment of Cancer: Aurora A Kinase Inhibitors and Dasatinib
Patent No. US9101631B2; Summary
|
Erica Golemis
|
Natalia Shalginskikh
|
|
196-MM
|
Modulators of Hsp70/ Dnak Function
Patent No. US9296687B2
|
Maureen Murphy
|
Natalia Shalginskikh
|
|
222-HB
|
A Highly Specific Antibody Targeting Tumor Endothelial Marker 7R
Patent No. US8883978B2; Summary
Patent No. US9534050B2
|
Hossein Borghaei
|
Tatiana Venkova
|
|
243-MC
|
Targeting of Cytochrome CYP1B1 in the Treatment of Head and Neck and Lung Cancers
Patent No. US9101603B2; Summary
|
Margie Clapper
|
Natalia Shalginskikh
|
|
250-MA
|
New Drug Target Site of HIV Integrase for AIDS Therapy
Patent No. US9533040B2; Summary
|
Mark Andrake
|
Natalia Shalginskikh
|
|
264-JP
|
Small Molecule Inhibitors of ACK1 for Treating Cancer and Dyskinesia in Parkinson’s Disease
Patent No. US8,658,655 B2; Summary
|
Jeffrey Peterson
|
Tatiana Venkova
|
|
276-GA
|
Rationally-designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
Patent No. US9611321B2; Summary
|
Gregory Adams
|
Inna Khartchenko
|
|
280-TY
|
Combination Inhibition of the Vitamin D Receptor and DNA Replication in the Treatment of Cancer
Patent No. US9265787B2; Summary
|
Timothy Yen
|
Tatiana Venkova
|
|
311-AB
|
Combination of DNA Repair Inhibition With Bendamustine or Gemcitabine in the Treatment of Cancer
Patent No. US8927516B2
|
Alfonso Bellacosa
|
Natalia Shalginskikh
|
|
314-VK
|
New Anticancer Zinc Chetatin Agents for Therapy of Advanced Prostate Cancer
Patent No. US9320736B2; Summary
|
Vladimir Kolenko
|
Natalia Shalginskikh
|
|
326-NB
|
Sensitization of Cancer Cells to DNA Damage by Inhibiting Kinases Essential for DNA Damage Checkpoint Control
Patent No. US9421203B2; Summary
|
Timothy Yen
|
Tatiana Venkova
|
|
337-ZY
|
Novel Treatment of Medulloblastoma by Inhibition of Leukotriene Synthesis and Activity
Patent No. US9616056B2; Summary
|
Zeng-Jie Yang
|
Natalia Shalginskikh
|
|
346-AB
|
Novel Methods for Inhibiting Growth and Proliferation of Melanoma Cells
Patent No. US11077121B2; Summary
|
Alfonso Bellacosa
|
Natalia Shalginskikh
|
|
349-IA
|
C-MYC as a Novel Biomarker of Cancer Therapeutic Efficacy
Patent No. US9993458B2; Summary
|
Igor Astsaturov
|
Natalia Shalginskikh
|
|
370-AT
|
Novel Class of PARP-1 Blockers for the Treatment of Prostate and Renal Cancers
Patent No. US9993458B2; Summary
|
Alexei Tulin
|
Natalia Shalginskikh
|
|
381-TY
|
Combined Inhibition of the Vitamin D Receptor and Poly (ADP) Ribose Polymerase-1 (PARP-1) in Cancer Therapy
Patent No. US9889141B2; Summary
Patent No. US10449200B2
|
Timothy Yen
|
Tatiana Venkova
|
|
394-EG
|
Systems and Methods for Treating Patients Having a Genetic Predisposition to Develop Prostate Cancer
Published Application No.WO2017049023A1; Summary
Patent No. US10724100B2
Other Patent Applications Pending
|
Erica Golemis
|
Tatiana Venkova
|
|
404-WE
|
Prodigiosin Analogs as Cancer Therapeutics
Patent No. US10654801B2; Summary
|
Wafik El-Deiry
|
Tatiana Venkova
|
|
407-SB
|
Viral-Based Cancer Gene Therapy and Treatment of Influenza Infection Through Induction of Cell Death
Published Application No.WO2018009541A1; Summary
|
Siddharth Balachandran
|
Natalia Shalginskikh
|
|
424-WE
|
MicroRNA as Targeting CDK4/6-Cell Cycle Pathways Treatment for Cancer
Published Application No.WO2018157026A1; Summary
|
Wafik El-Deiry
|
Tatiana Venkova
|
|
425-MA
|
Small Molecule Allosteric Inhibitors of HIV Integrase
Published Application No.WO2018140762A1; Summary
|
Mark Andrake
|
Natalia Shalginskikh
|
|
426-SA
|
Methods For Diagnosis And Treatment Of Patients Having Solid Tumors
Published Application No.US20200232041A1; Summary
|
Sanjeevani Arora
|
Tatiana Venkova
|
|
427-ZY
|
Cholesterol Synthesis Inhibitors Synergize with Smoothened Antagonist for Treatment of Hedgehog Pathway Malignancies
Published Application No.WO2018218114A1; Summary
|
Zeng-Jie Yang
|
Natalia Shalginskikh
|
|
429-RD
|
Chimera of Bone Morphogenic Protein 2 and the Mullerian Inhibiting Substance Type II Receptor Binding Region of Mullerian Inhibiting Substance
Published Application No.US20200010523A1; Summary
|
Roland Dunbrack
|
Tatiana Venkova
|
|
430-WE
|
Compounds For Repressing Cancer Cell Growth
Published Application No. US20190225614A1; Summary
|
Wafik El-Deiry
|
Tatiana Venkova
|
|
431-WE
|
High EGFR Somatic Mutation Frequency Targeting the TK Domain in Colorectal Cancer Patients with Microsatellite Instability (MSI)
Published Application No.WO2018157032A1; Summary
|
Wafik El-Deiry
|
Tatiana Venkova
|
|
432-WE
|
Dual Inhibition of CDK1 and HSP90 Destabilize HIF1a and Synergistically Induces Cancer Cell Death
Published Application No.US20180243306A1; Summary
Patent No. US10729692B2
|
Wafik El-Deiry
|
Tatiana Venkova
|
|
438-JD
|
Generating a Kinome Profile for Cancer Therapy
Published Application No.US2020046770A1; Summary
|
James Duncan
|
Natalia Shalginskikh
|
|
439-EC
|
Pancreatic Cancer Associated Desmoplastic Immune Checkpoint Inhibitor
Published Application No.WO2019074915A1; Summary
|
Edna Cukierman
|
Natalia Shalginskikh
|
|
441-JR
|
Development of a Panel of Markers Predicting Response of Breast Cancer Prevention
Published Application No.WO2019079167A1; Summary
|
Jose Russo
|
Natalia Shalginskikh
|
|
447-WE
|
TRAIL Upregulating miRNA with Apoptotic Activity
Published Application No.WO2019177928A1; Summary
|
Wafik El-Deiry
|
Tatiana Venkova
|
|
461-PA
|
Urinary DNA Detection for Monitoring of Urothelial Cancer
Published Application No.WO2019222325A1; Summary
|
Philip Abbosh
|
Natalia Shalginskikh
|
|
462-PM
|
Combination of Sunitinib with Farnesyl-Transferase Inhibitors as a Next Generation Therapeutic Approach
Published Application No.WO2020092517A1; Summary
|
Petr Makhov
|
Natalia Shalginskikh
|
|
469-ME
|
Radiotherapeutic Combination Therapy For Treatment of Cancer
Published Application No.WO2020145977A1
|
Martin Edelman
|
Tatiana Venkova
|
|
477-DC
|
A novel antibody for the treatment of ovarian and other cancers
Published Application No.WO2020167927A1
|
Denise Connolly
|
Natalia Shalginskikh
|
|
482-SB
|
Protein Kinase Inhibitors and Uses Thereof for the Treatment of Diseases and Conditions
Published Application No. WO2020232190A1
|
Siddharth Balachandran
|
Natalia Shalginskikh
|
|
484-EC
|
Reagent/Drug(s) to Prevent NetricGI/NGLI Engagement
Published Application No. WO2020219854A1
|
Edna Cukierman
|
Natalia Shalginskikh
|
|
485-JK
|
Using Chemical Biology to Enable Precision Immuno-Oncology
Published Application No. WO2020223273A2; Summary
|
John Karanicolas
|
Tatiana Venkova
|
|
493-LW
|
Methods of Inhibiting Proliferation of Estrogen-Independent Cancer Cells
Patent No. US9677072B2; Summary
|
Louis Weiner
|
Natalia Shalginskikh
|
|
494-AP
|
Novel Druggable Targets on the Interface of Oncogenic and Metabolic Pathways
Published Application No. WO2020243063A1; Summary
|
Andrzej Ptasznik
|
Tatiana Venkova
|
|
498-PA
|
Azolium Salts for Treatment of Non-Muscle Invasive Bladder Cancer
Patent No. US11197873B2; Summary
|
Philip Abbosh
|
Natalia Shalginskikh
|
|
499-JD
|
Combination Therapy for Treatment of Cancer (PROTACs and mTORC inhibitors)
Published Application No. WO2021026349A1; Summary
|
James Duncan
|
Natalia Shalginskikh
|
|
520-AB
|
TDG inhibitors for the treatment of cancer and other diseases
Published Application No. WO2022047288A1; Summary
|
Alfonso Bellacosa
|
Natalia Shalginskikh
|
|
522-MC
|
Estrogen Metabolite Levels and EGFR Mutations in Lung Cancer Risk Stratification and Treatment
Published Application No. WO2021142408A1
|
Margie Clapper
|
Natalia Shalginskikh
|
|
534-JR
|
Treatment of females having BRCA1/2 mutations with human chorionic gonadotropin to reduce the risk of developing breast cancer
Published Application No. WO2022125417A1; Summary
|
Jose Russo
|
Natalia Shalginskikh
|
|
536-EK
|
Treatment Of Non-Alcoholic Steatohepatitis (NASH) With IL-27 Antibody
Published Application No. US20220089714A1
|
Ekaterina Koltsova
|
Natalia Shalginskikh
|
|
541-JW
|
Treatment of Integrin-Related Disorders With Stapled Peptides
Patent Pending; Summary
|
Jinhua Wu
|
Tatiana Venkova
|
|
543-JRW
|
Compositions And Methods For Regulating EGFR Amplification In Cancer Cells For Improving Efficacy Of EGFR-Targeted Anti-Cancer Agents
Published Application No. WO2021097464A1
|
Johnathan R Whetstine
|
Tatiana Venkova
|
|
544-JK
|
Compositions and Methods for Modulation of Antibody Activity
Patent Pending; Summary in 485-JK.
|
John Karanicolas
|
Tatiana Venkova
|
|
546-JT
|
Malignant Mesothelioma Susceptibility as a Result of Germline Gene Alteration
Patent Pending; Summary
|
Joseph Testa
|
Tatiana Venkova
|
|
550-PA
|
Personalized therapeutic cancer vaccines based on aberrantly translated introns for patients with tumors harboring
SETD2 mutations
Patent Pending
|
Philip Abbosh
|
Natalia Shalginskikh
|
|
552-JD
|
Combining ABCB1 inhibitors with PROTAC therapies to improve therapeutic responses
Patent Pending; Summary
|
James Duncan
|
Natalia Shalginskikh
|
